Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

556
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
556
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
293
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Candidozyma auris utilizes transferrin, but not heme-bound iron for in vivo virulence.

bioRxiv : the preprint server for biology·2026
Same author

In-dwelling microfluidic device for precise and reliable intranasal drug delivery during freely moving behavior.

Lab animal·2026
Same author

CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

Molecular cancer therapeutics·2026
Same author

Physiologically Based Pharmacokinetic Model for Clinical Translation and Prediction of Drug Interaction of the Major Kratom Alkaloid, Mitragynine.

ACS pharmacology & translational science·2026
Same author

Diagnostic performance of a human over-the-counter urine test to detect kratom alkaloids and metabolites in canine urine.

American journal of veterinary research·2025
Same author

In Vitro Pharmacology of Mitragynine at α-Adrenoceptors.

ACS chemical neuroscience·2025

Related Experiment Video

Updated: Sep 8, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.7K

Evaluating the drug interactions in kratom usage: clinical application.

Leena R Dhoble1,2, Abhishek Gour1, Christopher R McCurdy1,2,3

  • 1Department of Pharmaceutics, University of Florida, Gainesville, FL, USA.

Expert Opinion on Drug Metabolism & Toxicology
|June 16, 2025
PubMed
Summary
This summary is machine-generated.

Kratom (Mitragyna speciosa) has stimulant and opioid-like effects, offering potential for pain management and opioid use disorder. Understanding its drug interactions is crucial for safe clinical use and improved patient outcomes.

Keywords:
KratomMitragyna speciosadrug interactionsmitragyninepharmacodynamicspharmacokinetics

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Related Experiment Videos

Last Updated: Sep 8, 2025

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

11.7K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Area of Science:

  • Pharmacology
  • Ethnobotany
  • Drug Interactions

Background:

  • Mitragyna speciosa (kratom) is a Southeast Asian tree with traditional ethnopharmacological uses.
  • Kratom exhibits a dual pharmacological profile: stimulant at low doses and opioid-like at high doses.
  • Its potential applications include pain management and mitigating opioid use disorder.

Purpose of the Study:

  • To evaluate the clinical applications of kratom by examining its drug interactions.
  • To highlight the importance of safe clinical practices and protocols for kratom use.
  • To inform clinical practice and improve user safety.

Main Methods:

  • Systematic literature search of Google Scholar and PubMed.
  • Inclusion of data from the FAERS database.
  • Evaluation of existing evidence on kratom's pharmacokinetic and pharmacodynamic interactions.

Main Results:

  • Kratom's bioactive alkaloids can interact with concurrent medications.
  • These interactions may affect pharmacokinetics and pharmacodynamics.
  • Potential for adverse effects or compromised therapeutic outcomes exists.

Conclusions:

  • Evaluating drug interactions in kratom usage is clinically imperative.
  • Expert opinion is provided on the clinical relevance of kratom-drug interactions.
  • Future research directions are proposed to enhance understanding and safety.